TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories

Objectives: Preanalytical phase quality, which begins with a request for testing and continues with patient preparation, sample collection, transport, processing and storage, is essential for coagulation tests. The Turkish Biochemical Society Preanalytical Phase Working Group created a survey to evaluate the preanalytical phase prac tices for coagulation laboratories in our country. Methods: The survey consisted of a total of 26 questions and included almost all steps of the preanalytical phase. Results: Fifty-four laboratory specialists have partici pated in the study. The survey results showed that partic ipants have different practices for most stages of the preanalytical phase for coagulation tests. Conclusion: According to the survey results, a national guideline may help standardisation of the preanalytical phase for coagulation tests in our country and increasing training in this respect would contribute to achieving ac curate test results.

Anahtar Kelime:

TBD preanalitik evre çalişma grubu anket çalişmasi – Koagülasyon laboratuvarlarinda preanalitik evre

Öz:

Amaç: Test istemi ile başlayan, hasta hazırlığı, numune alma, hazırlama ve transportu ve numune depolama ve saklama basamaklarını içeren preanalitik evre kalitesi, koagülasyon testleri için son derece önemlidir. Türk Biyo kimya Derneği-Preanalitik Evre Çalışma Grubu, ülkemizde koagülasyon laboratuvarlarında preanalitik evre uygula malarını değerlendirmek amacıyla bir anket düzenlendi. Gereç ve Yöntem: Anket toplam 26 sorudan oluşmaktaydı ve preanaliitik evrenin hemen hemen tüm basamaklarını içermekteydi. Bulgular: Çalışmaya elli dört laboratuvar uzmanı katıldı. Çalışma sonuçlarına göre katılımcıların, koagülasyon tes tleri için preanalitik evrenin çoğu basamaklarında farklı uygulamalara sahip oldukları görüldü. Sonuç: Anket sonuçlarına göre, ulusal bir rehber ülke mizde koagülasyon testleri için preanalitik evrenin stand ardizasyonuna yardımcı olabilir ve bu konuda eğitimlerin arttırılması doğru test sonuçlarının elde edilmesine katkıda bulunacaktır.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Lippi G, Favaloro EJ, Franchini M, Guidi GC. Milestones and perspectives in coagulation and hemostasis. Semin Thromb Hemost 2009;35:9–22.
2. Favaloro EJ, McVicker W, Hamdam S, Hocker N. Improving the harmonisation of the international normalized ratio (INR): time to think outside the box?. Clin Chem Lab Med 2010;48:1079– 90.
3. Lippi G, Favaloro EJ. Activated partial thromboplastin time: new tricks for an old dogma. Semin Thromb Hemost 2008;34:604–11.
4. Mina A, Favaloro EJ, Mohammed S, Koutts J. A laboratory evaluation into the short activated partial thromboplastin time. Blood Coagul Fibrin 2010;21:152–7.
5. Lippi G, Franchini M, Favaloro EJ. Pharmacogenetics of vitamin K antagonists: useful or hype?. Clin Chem Lab Med 2009;47: 503–15.
6. Plebani M. Errors in clinical laboratories or errors in laboratory medicine?. Clin Chem Lab Med 2006;44:750–9.
7. CLSI. Collection transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays: approved guideline, 5th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008. CLSI document H21-A5.
8. Lippi G, Banfi G, Buttarello M, Ceriotti F, Daves M, Dolci A, et al. Recommendations for detection and management of unsuitable samples in clinical laboratories. Clin Chem Lab Med 2007;45: 728–36.
9. Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M. On behalf of British committee for standards in hematology. Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol 2013; 35:1–13.
10. Favaloro EJ, Lippi G, Koutts J. Laboratory testing of anticoagulants: the present and the future. Pathology 2011;43: 682–92.
11. Favaloro EJ, Lippi G. Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?. Clin Chem Lab Med 2011;49:755–7.
12. Lippi G, Favaloro EJ, Salvagno GL, Franchini M. Laboratory assessment and perioperative management of patients on antiplatelet therapy: from the bench to the bedside. Clin Chim Acta 2009;405:8–16.
13. Douxfils J, Mullier F, Loosen C, Chatelain C, Chatelain B, Dogné JM. Assessment of the impact of rivaroxaban on coagulation assays:laboratory recommendations for the monitoring of rivaroxaban and review of the literature. Thromb Res 2012;130: 956–66.
14. Douxfils J, Chatelain C, Chatealin B, Dogné JM, Mullier F. Impact of apixaban on routine and specific coagulation assays:a practical laboratory guide. Thromb Haemost 2013;110:283–97.
15. Ruff CT, Giugliano RP, Braunwald E, Morrow DA, Murphy SA, Kuder JF, et al. Association between edoxaban dose, concentration, anti-factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet 2015;385:2288–95.
16. Favaloro EJ, McDonald D, Lippi G. Laboratory investigation of thrombophilia: the good, the bad, and the ugly. Semin Thromb Hemost 2009;35:695–710.
17. Heleen van Ommen C, Middeldorp S. Thrombophilia in childhood: to test or not to test. Semin Thromb Hemost 2011;37: 794–801.
18. Lima-Oliveira G, Salvagno GL, Lippi G, DaneseE, GelatiM, MontagnanaM, et al. Could light meal jeopardize laboratory coagulation tests?. Biochem Med (Zagreb) 2014;24:343–9.
19. Lippi G, Lima-Oliveira G, Salvagno GL, Montagnana M, Gelati M, Picheth G, et al. Influence of a light meal on routine haematological tests. Blood Transfus 2010;8:94–9.
20. Simundic AM, Cornes M, Grankvist K, Lippi G, Nybo M. Standardisation of collection requirements for fasting samples for the Working Group on Preanalytical Phase (WG-PA) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). Clin Chim Acta 2014;432:33–7.
21. Turkish Biochemical Society. National guideline for venous blood collection (phlebotomy), 2nd ed. 978-605-87229-3-4. Turkey; 2018.
22. Lippi G, Salvagno GL, Montagnana M, Guidi GC. Short-term venous stasis influences routine coagulation testing. Blood Coagul Fibrin 2005;16:453–8.
23. Lima-Oliveira G, Salvagno GL, Lippi G, Montagnana M, Scartezini M, Picheth G, et al. Elimination of the venous stasis error for routine coagulation testing by transillumination. Clin Chim Acta 2011;412:1482–4.
24. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol 1997;107:105–10.
25. Duncan EM, Casey CR, Duncan BM, Lloyd JV. Effect of concentration of trisodium citrate anticoagulant on the calculation of the international normalized ratio and the international sensitivity index of thromboplastin. Thromb Haemost 1994;72:84–8.
26. Marlar RA, Potts RM, Marlar AA. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. Am J Clin Pathol 2006;126: 400–5.
27. CLSI. Procedures for the collection of diagnostic blood specimens by venipuncture. Approved Standard., 6th ed. Wayne PA: Clinical and Laboratory Standards Institute; 2007. CLSI document GP41-A6.
28. Lippi G, Salvagno GL, Montagnana M, Guidi GC. Influence of primary sample mixing on routine coagulation testing. Blood Coagul Fibrin 2007;18:709–11.
29. Parenmark A, Landberg E. To mix or not to mix venous blood samples collected in vacuum tubes?. Clin Chem Lab Med 2011;49: 2061–3.
30. Zürcher M, Sulzer I, Barizzi G, Lämmle B, Alberio L. Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature. Thromb Haemost 2008;99:416–26.
31. Awad MA, Selim TE, Al-Sabbagh FA. Influence of storage time and temperature on international normalized ratio (INR) levels and plasma activities of vitamin K dependent clotting factors. Hematology 2004;9:333–7.
32. Van den Besselaar AM, Meeuwisse-Braun J, Jansen-Grüter R, Bertina RM. Monitoring heparin therapy by the activated partial thromboplastin time—the effect of pre-analytical conditions. Thromb Haemost 1987;57:226–31.
33. Adcock DA, Kressin DC, Marlar RA. The effect of time and temperature variables on routine coagulation tests. Blood Coagul Fibrinol 1998;9:463–70.
34. O’Neill EM, Rowley J, Hansson-Wicher H, McCarter S, Ragno G, Valeri CR. Effect of 24-hour whole-blood storage on plasma clotting factors. Transfusion 1999;39:488–91.
35. Turkish Biochemical Society. Guideline for centrifuge use in medical laboratories. 978-605-87229-4-1. Turkey; 2017.
36. Favaloro EJ, Funk DM, Lippi G. Pre-analytical variables in coagulation testing associated with diagnostic errors in hemostasis. Lab Med 2012;43:1–10.
37. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008; 46:764–72.
38. Lippi G, Plebani M, Favaloro EJ. Interference in coagulation testing: focus on spurious hemolysis, icterus, and lipemia. Semin Thromb Hemost 2013;39:258–66.
39. McCraw A, Hillarp A, Echenagucia M. Considerations in the laboratory assessment of haemostasis. Haemophilia 2010;16: 74–8.
40. Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, et al. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation. Thromb Haemost 2006;96:73–8.
41. Romero A, Cobos A, Gómez J, Muñoz M. Role of training activities for the reduction of pre-analytical errors in laboratory samples from primary care. Clin Chim Acta 2012; 413:166–9. Jan 18.

APA	Şeneş M, Bercik Inal B, aksungar f, ÇINAROĞLU İ, sonmez (atay) c, EKER P, AYKAL G, HAKLIGÖR A, Gümüş A, ORHAN B, GÜÇEL F, Yilmaz C, coşkun c, TANELİ F, Çolak A, Yucel D (2021). TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories. , 13 - 21. 10.1515/tjb-2019-0512
Chicago	Şeneş Mehmet,Bercik Inal Berrin,aksungar fehime benli,ÇINAROĞLU İpek,sonmez (atay) cıgdem,EKER Pınar,AYKAL Güzin,HAKLIGÖR Aylin,Gümüş Alper,ORHAN Bağnu,GÜÇEL Funda,Yilmaz Canan,coşkun cihan,TANELİ FATMA,Çolak Ayfer,Yucel Dogan TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories. (2021): 13 - 21. 10.1515/tjb-2019-0512
MLA	Şeneş Mehmet,Bercik Inal Berrin,aksungar fehime benli,ÇINAROĞLU İpek,sonmez (atay) cıgdem,EKER Pınar,AYKAL Güzin,HAKLIGÖR Aylin,Gümüş Alper,ORHAN Bağnu,GÜÇEL Funda,Yilmaz Canan,coşkun cihan,TANELİ FATMA,Çolak Ayfer,Yucel Dogan TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories. , 2021, ss.13 - 21. 10.1515/tjb-2019-0512
AMA	Şeneş M,Bercik Inal B,aksungar f,ÇINAROĞLU İ,sonmez (atay) c,EKER P,AYKAL G,HAKLIGÖR A,Gümüş A,ORHAN B,GÜÇEL F,Yilmaz C,coşkun c,TANELİ F,Çolak A,Yucel D TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories. . 2021; 13 - 21. 10.1515/tjb-2019-0512
Vancouver	Şeneş M,Bercik Inal B,aksungar f,ÇINAROĞLU İ,sonmez (atay) c,EKER P,AYKAL G,HAKLIGÖR A,Gümüş A,ORHAN B,GÜÇEL F,Yilmaz C,coşkun c,TANELİ F,Çolak A,Yucel D TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories. . 2021; 13 - 21. 10.1515/tjb-2019-0512
IEEE	Şeneş M,Bercik Inal B,aksungar f,ÇINAROĞLU İ,sonmez (atay) c,EKER P,AYKAL G,HAKLIGÖR A,Gümüş A,ORHAN B,GÜÇEL F,Yilmaz C,coşkun c,TANELİ F,Çolak A,Yucel D "TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories." , ss.13 - 21, 2021. 10.1515/tjb-2019-0512
ISNAD	Şeneş, Mehmet vd. "TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories". (2021), 13-21. https://doi.org/10.1515/tjb-2019-0512

APA	Şeneş M, Bercik Inal B, aksungar f, ÇINAROĞLU İ, sonmez (atay) c, EKER P, AYKAL G, HAKLIGÖR A, Gümüş A, ORHAN B, GÜÇEL F, Yilmaz C, coşkun c, TANELİ F, Çolak A, Yucel D (2021). TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories. Türk Biyokimya Dergisi, 46(1), 13 - 21. 10.1515/tjb-2019-0512
Chicago	Şeneş Mehmet,Bercik Inal Berrin,aksungar fehime benli,ÇINAROĞLU İpek,sonmez (atay) cıgdem,EKER Pınar,AYKAL Güzin,HAKLIGÖR Aylin,Gümüş Alper,ORHAN Bağnu,GÜÇEL Funda,Yilmaz Canan,coşkun cihan,TANELİ FATMA,Çolak Ayfer,Yucel Dogan TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories. Türk Biyokimya Dergisi 46, no.1 (2021): 13 - 21. 10.1515/tjb-2019-0512
MLA	Şeneş Mehmet,Bercik Inal Berrin,aksungar fehime benli,ÇINAROĞLU İpek,sonmez (atay) cıgdem,EKER Pınar,AYKAL Güzin,HAKLIGÖR Aylin,Gümüş Alper,ORHAN Bağnu,GÜÇEL Funda,Yilmaz Canan,coşkun cihan,TANELİ FATMA,Çolak Ayfer,Yucel Dogan TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories. Türk Biyokimya Dergisi, vol.46, no.1, 2021, ss.13 - 21. 10.1515/tjb-2019-0512
AMA	Şeneş M,Bercik Inal B,aksungar f,ÇINAROĞLU İ,sonmez (atay) c,EKER P,AYKAL G,HAKLIGÖR A,Gümüş A,ORHAN B,GÜÇEL F,Yilmaz C,coşkun c,TANELİ F,Çolak A,Yucel D TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories. Türk Biyokimya Dergisi. 2021; 46(1): 13 - 21. 10.1515/tjb-2019-0512
Vancouver	Şeneş M,Bercik Inal B,aksungar f,ÇINAROĞLU İ,sonmez (atay) c,EKER P,AYKAL G,HAKLIGÖR A,Gümüş A,ORHAN B,GÜÇEL F,Yilmaz C,coşkun c,TANELİ F,Çolak A,Yucel D TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories. Türk Biyokimya Dergisi. 2021; 46(1): 13 - 21. 10.1515/tjb-2019-0512
IEEE	Şeneş M,Bercik Inal B,aksungar f,ÇINAROĞLU İ,sonmez (atay) c,EKER P,AYKAL G,HAKLIGÖR A,Gümüş A,ORHAN B,GÜÇEL F,Yilmaz C,coşkun c,TANELİ F,Çolak A,Yucel D "TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories." Türk Biyokimya Dergisi, 46, ss.13 - 21, 2021. 10.1515/tjb-2019-0512
ISNAD	Şeneş, Mehmet vd. "TBS preanalytical phase working group survey study – preanalytical phase in coagulation laboratories". Türk Biyokimya Dergisi 46/1 (2021), 13-21. https://doi.org/10.1515/tjb-2019-0512